首页> 美国卫生研究院文献>Cancer Science >Intracellular Signal‐transducing Elements Involved in Transendothelial Migration of Lymphoma Cells
【2h】

Intracellular Signal‐transducing Elements Involved in Transendothelial Migration of Lymphoma Cells

机译:涉及淋巴瘤细胞跨内皮迁移的细胞内信号转导元件

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To investigate the molecular mechanisms underlying transendothelial migration of tumor cells, an essential process for their hematogenous dissemination, we developed an in vitro model system that allows the separate monitoring of cell adhesion and transmigration processes. This system uses a human pre‐B lymphoma cell line, Nalm‐6, and a cultured mouse endothelial cell line, KOP2.16. Nalm‐6 cells rapidly adhered to KOP2.16 and subsequently transmigrated underneath them. Using this model, we examined the effects on transendothelial migration, of various reagents which specifically interfere with the function of intracellular signal transduction molecules. Treatment of Nalm‐6 cells with wortmannin (WMN), herbimycin A, pertussis toxin, or C3 exoenzyme of Clostridium botulinum, which specifically inhibit P13 kinase and/or myosin light chain kinase, herbimycin‐sensitive tyrosine kinases, heterotrimeric G proteins, and the small G proteins rho/rac, respectively, reduced transmigration in a dose‐dependent manner. Pretreatment of KOP2.16 endothelial cells with WMN also reduced transmigration in a dose‐dependent manner. Binding of Nalm‐6 to KOP2.16 was not affected, even when Nalm‐6 or KOP2.16 cells were pretreated with these inhibitors, indicating that the reduction of transmigration was not due to a reduction of Nalm‐6 binding to KOP2.16. These results also indicate that the signal transduction pathway(s) involved in transmigration can be dissociated from that of adhesion. Our results support the notion that endothelial cells are not a passive barrier in lymphoma extravasation, but that they assist lymphoma cell extravasation.
机译:为了研究肿瘤细胞经内皮迁移的分子机制,这是其血行性传播的基本过程,我们开发了一种体外模型系统,该系统可单独监测细胞粘附和迁移过程。该系统使用人类Pre-B淋巴瘤细胞系Nalm-6和培养的小鼠内皮细胞系KOP2.16。 Nalm-6细胞迅速粘附于KOP2.16,随后在其下方迁移。使用该模型,我们检查了各种试剂对跨内皮迁移的影响,这些试剂特异性干扰细胞内信号转导分子的功能。用渥曼青霉素(WMN),除草霉素A,百日咳毒素或肉毒梭菌C3外切酶处理Nalm-6细胞,可特异性抑制P13激酶和/或肌球蛋白轻链激酶,除草霉素敏感的酪氨酸激酶,异三聚体G蛋白和小G蛋白rho / rac分别以剂量依赖的方式减少了迁移。 WMN预处理KOP2.16内皮细胞也以剂量依赖的方式减少了迁移。即使使用这些抑制剂预处理Nalm-6或KOP2.16细胞,Nalm-6与KOP2.16的结合也不会受到影响,这表明转运减少不是由于Nalm-6与KOP2.16的结合减少所致。 。这些结果还表明,与迁移有关的信号转导途径可以与粘附途径分离。我们的结果支持以下观点:内皮细胞不是淋巴瘤外渗的被动障碍,但它们有助于淋巴瘤细胞外渗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号